Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 450

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 450
---
 the Company agreed to issue 568,278 PPCs and 37,783 NLS Preferred Shares, as well as warrants to purchase 393,939 NLS Common Shares at an exercise price of $1.80 per share, for aggregate gross proceeds of $1million. The second closing occurred on June27, 2025. In addition, on June26, 2025, the Company and Alpha entered into a side letter pursuant to which the Company agreed to issue Alpha pre -fundedwarrants to purchase 485,000 NLS Common Shares in lieu of the Company’s prior agreement, contained in the March 2025 SPA, to issue Alpha 435,000 NLS Preferred Shares (or their equivalent) to compensate Alpha for certain price protection issuances and registration obligations. The initial and second closings of the March 2025 Offering resulted in aggregate gross proceeds to the Company of $3 million. The Company intends to use the net proceeds from the March 2025 Offering for working capital and general corporate purposes, including for expenses relating to the Merger. Further, on March31, 2025, the Company entered into a common shares purchase agreement with Alpha, or the Facility SPA, relating to a committed equity facility. Pursuant to the Facility SPA, the Company has the right from time to time at its option to sell to Alpha up to $25.0million of the NLS Common Shares, subject to certain conditions and limitations set forth in the Facility SPA. Upon the initial satisfaction of the conditions to Alpha’s obligation to purchase NLS Common Shares set forth in the Facility SPA, or the Commencement, including that a registration statement registering the resale by Alpha of the NLS Common Shares under the Securities Act that may be sold to it by the Company under the Facility SPA, or the Initial Resale Registration Statement, is declared effective by the SEC and a final prospectus relating thereto is filed with the SEC, the Company will have the right, but not the obligation, from time to time at its sole discretion until the first day of the month next following the 36 -monthperiod from and after Commencement, to direct Alpha to purchase up to a specified maximum amount of NLS Common Shares as set forth in the Facility SPA by delivering written notice to Alpha prior to the commencement of trading on any trading day. The purchase price of the NLS Common Shares that the Company elects to sell to Alpha pursuant to the Facility SPA will be 95% of the volume weighted average price of the